CETP Inhibitor Powder Anacetrapib / MK-0859

CETP Inhibitor Powder Anacetrapib / MK-0859 For Reduce Cholesterol CAS:875446-37-0

Just try a small order to start our cooperation, we will NOT make you down !
Any products interested pls let me know I will give info.in details.
[email protected]
Skype:live:kathelin_4
WhataApp:+8618872220706

Product Name: ANACETRAPIB
CAS:875446-37-0
MF:C30H25F10NO3
MW:637.508432
EINECS:-0
Synonyms:Anacetrapib;Mk0859;Mk-0859;Unii-p7T269pr6s;(4S,5R)-5-[3,5-Bis(trifluoromethyl)phenyl]-3-[[4'-fluoro-5'-isopropyl-2'-methoxy-4-(trifluoromethyl)biphenyl-2-yl]methyl]-4-methyl-1,3-oxazolidin-2-one;(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-({2-[4-fluoro-2-methoxy-5-(propan-2-yl)phenyl]-5-(trifluoromethyl)phenyl}methyl)-4-methyl-1,3-oxazolidin-2-one;Anacetrapib(MK0859);2-Oxazolidinone, 5-[3,5-bis(trifluoroMethyl)phenyl]-3-[[4'-fluoro-2'-Methoxy-5'-(1-Methylethyl)-4-(trifluoroMethyl)[1,1'-biphenyl]-2-yl]Methyl]-4-Methyl-, (4S,5R)-

Anacetrapib is a CETP inhibitor which was being developed to treat elevated cholesterol levels in an effort prevent cardiovascular disease.In 2017 its development was abandoned by Merck.

Evidence
A 2017 review found that while the medication improves cholesterol levels in the blood it does not decrease the risk of heart problems in those at high risk.